These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 25086399)

  • 41. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
    Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
    J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines.
    Yan W; Chen W; Huang L
    Mol Immunol; 2007 Jul; 44(15):3672-81. PubMed ID: 17521728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CpG oligodeoxynucleotides activate dendritic cells in vivo and induce a functional and protective vaccine immunity against a TERT derived modified cryptic MHC class I-restricted epitope.
    Cornet S; Menez-Jamet J; Lemonnier F; Kosmatopoulos K; Miconnet I
    Vaccine; 2006 Mar; 24(11):1880-8. PubMed ID: 16300869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted liposomal delivery of TLR9 ligands activates spontaneous antitumor immunity in an autochthonous cancer model.
    Hamzah J; Altin JG; Herringson T; Parish CR; Hämmerling GJ; O'Donoghue H; Ganss R
    J Immunol; 2009 Jul; 183(2):1091-8. PubMed ID: 19561111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization.
    Jiao X; Wang RY; Feng Z; Alter HJ; Shih JW
    Hepatology; 2003 Feb; 37(2):452-60. PubMed ID: 12540796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer.
    Farzad N; Barati N; Momtazi-Borojeni AA; Yazdani M; Arab A; Razazan A; Shariat S; Mansourian M; Abbasi A; Saberi Z; Badiee A; Jalali SA; Jaafari MR
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):665-673. PubMed ID: 30829072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine.
    Disis ML; Grabstein KH; Sleath PR; Cheever MA
    Clin Cancer Res; 1999 Jun; 5(6):1289-97. PubMed ID: 10389911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved Immunogenicity Against a Her2/neu-Derived Peptide by Employment of a Pan HLA DR-Binding Epitope and CpG in a BALB/c Mice Model.
    Tahaghoghi-Hajghorbani S; Tavakkol-Afshari J; Jaafari MR; Ghaffari-Nazari H; Masoumi E; Jalali SA
    Anticancer Agents Med Chem; 2017; 17(6):851-858. PubMed ID: 27924731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The synergy between structural stability and DNA-binding controls the antibody production in EPC/DOTAP/DOPE liposomes and DOTAP/DOPE lipoplexes.
    de la Torre LG; Rosada RS; Trombone AP; Frantz FG; Coelho-Castelo AA; Silva CL; Santana MH
    Colloids Surf B Biointerfaces; 2009 Oct; 73(2):175-84. PubMed ID: 19540734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.
    Vasievich EA; Chen W; Huang L
    Cancer Immunol Immunother; 2011 May; 60(5):629-38. PubMed ID: 21267720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses.
    Whitmore MM; Li S; Falo L; Huang L
    Cancer Immunol Immunother; 2001 Dec; 50(10):503-14. PubMed ID: 11776372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of cytotoxic T-lymphocytes and antitumor activity by a liposomal lipopeptide vaccine.
    Chen W; Huang L
    Mol Pharm; 2008; 5(3):464-71. PubMed ID: 18266319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liposome-mediated DNA immunisation via the subcutaneous route.
    Perrie Y; McNeil S; Vangala A
    J Drug Target; 2003; 11(8-10):555-63. PubMed ID: 15203925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N; Mukherjee S; Das L; Das PK
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liposomal CpG-ODN: An in vitro and in vivo study on macrophage subtypes responses, biodistribution and subsequent therapeutic efficacy in mice models of cancers.
    Nikoofal-Sahlabadi S; Matbou Riahi M; Sadri K; Badiee A; Nikpoor AR; Jaafari MR
    Eur J Pharm Sci; 2018 Jul; 119():159-170. PubMed ID: 29660463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells.
    Filion MC; Phillips NC
    Biochim Biophys Acta; 1997 Oct; 1329(2):345-56. PubMed ID: 9371426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antitumor effects obtained by autologous Lewis lung cancer cell vaccine engineered to secrete mouse interleukin 27 by means of cationic liposome.
    Zhang J; Tian H; Li C; Cheng L; Zhang S; Zhang X; Wang R; Xu F; Dai L; Shi G; Chen X; Li Y; Du T; Deng J; Liu Y; Yang Y; Wei Y; Deng H
    Mol Immunol; 2013 Oct; 55(3-4):264-74. PubMed ID: 23522926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model.
    Liu C; Chu X; Sun P; Feng X; Huang W; Liu H; Ma Y
    Hum Vaccin Immunother; 2018 Apr; 14(4):931-940. PubMed ID: 29271696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The adjuvant effect of melanin is superior to incomplete Freund's adjuvant in subunit/peptide vaccines in mice.
    Cuzzubbo S; Banissi C; Rouchon MS; Tran T; Tanchot C; Tartour E; Carpentier AF
    Cancer Immunol Immunother; 2020 Dec; 69(12):2501-2512. PubMed ID: 32561966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.